Xenon Pharmaceuticals Inc.

(XENE) Trade

By |

Profile

Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders, including the rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901 and XEN496 for Epilepsy, XEN007 for Orphan neurological and Nav1.7 oral inhibitors for Pain. Geographically the activities are carried out through Canada.

Contact Information

Website: www.xenon-pharma.com
Email: investors@xenon-pharma.com
Main Phone: +1 604 484-3300
Address: 200-3650 Gilmore Way
State: BC
City / Town: Burnaby
Country: CAN
Postal Code: V5G 4W8

Issuer Information

Exchange: NSD
CEO: Simon Pimstone
Employees: 104
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Profile

Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders, including the rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901 and XEN496 for Epilepsy, XEN007 for Orphan neurological and Nav1.7 oral inhibitors for Pain. Geographically the activities are carried out through Canada.

Contact Information

Website: www.xenon-pharma.com
Email: investors@xenon-pharma.com
Main Phone: +1 604 484-3300
Address: 200-3650 Gilmore Way
State: BC
City / Town: Burnaby
Country: CAN
Postal Code: V5G 4W8

Issuer Information

Exchange: NSD
CEO: Simon Pimstone
Employees: 104
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

$ 13.22 $ -0.09 (-0.68%)
Last Price 13.22 Change $ -0.09 Change % -0.68 Tick N/A
Bid 12.42 Bid Size 100.00 Ask 13.68 Ask Size 100.00
Open 13.26 High 13.40 Low 13.01 Prev Close 13.31
Last Trade Volume 169,526 52 Wk Hi 18.46 52 Wk Low 7.00
Market Cap 462.4 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 34,974,119.00 EPS (TTM) -1.33 PE Ratio N/A Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 5 42
Number of Buys 1 35
Number of Sells 4 7
Net Activity -2431626 -2092506
Last 10 Buys Shares
Mohammad Azab 1,000
Mohammad Azab 1,000
Mohammad Azab 1,000
Mohammad Azab 1,000
Raymond J. Winquist 1,000
Mohammad Azab 1,000
James R. Empfield 1,000
Mark N. Lampert 1,000
Mark N. Lampert 1,000
Michael Hayden 1,000
Last 10 Sell Shares
Frank Holler 1,000
Frank Holler 1,000
Frank Holler 1,000
Frank Holler 1,000
Frank Holler 1,000
Y. Paul Goldberg 1,000
Y. Paul Goldberg 1,000
Y. Paul Goldberg 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 9 9 9 9
Low Target Price Estimate 9 9 9 9
Mean Target Price Estimate 9 9 9 9
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 05/16/18 05/16/18 05/16/18 05/16/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 3 3 3 3
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1